The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
about
Atrophy rates accelerate in amnestic mild cognitive impairment.Differentiating Alzheimer disease-associated aggregates with small molecules.Amyloid load in nondemented brains correlates with APOE e4.Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease.Pattern separation and pattern completion in Alzheimer's disease: evidence of rapid forgetting in amnestic mild cognitive impairment.Amyloid imaging and memory change for prediction of cognitive impairment.Amyloid-β associated cortical thinning in clinically normal elderly.Cerebrovascular lesions induce transient β-amyloid deposition.Asymptomatic Alzheimer's disease: a prodrome or a state of resilience?Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease.Tract-based analysis of white matter degeneration in Alzheimer's disease.Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease.Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal PathologyIncipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses.Perivascular neuritic dystrophy associated with cerebral amyloid angiopathy in Alzheimer's disease.Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.Symposium overview: Chemical senses and mechanisms of neurodegenerative diseases.Predicting the location of entorhinal cortex from MRI.Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease.Mercury induced the Accumulation of Amyloid Beta (Aβ) in PC12 Cells: The Role of Production and Degradation of Aβ.A 2-process model for neuropathology of Alzheimer's disease.Olfactory memory impairment in neurodegenerative diseases.[18F]FDG-PET in patients with Alzheimer's disease: marker of disease spread.Hippocampal subregions are differentially affected in the progression to Alzheimer's disease.Active immunization of mice with an Abeta-Hsp70 vaccine.Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder.Influence of magnetic field strength and image registration strategy on voxel-based morphometry in a study of Alzheimer's disease.Depressive symptoms increase the likelihood of cognitive impairment in elderly people with subclinical Alzheimer pathology.Origin of metastable oligomers and their effects on amyloid fibril self-assembly
P2860
Q30489846-C2AE5E72-8957-4A02-B7F5-D083B00BAE7CQ33296123-A93480B7-06EA-4831-8537-D524E17592E2Q33775494-75EDB81B-E165-49A9-9C22-BE7663C8FC3BQ33828966-910B52FF-EF76-4EFF-AD91-AB5ABEC0C628Q33862533-8646B967-8BBE-42C4-B7DE-2167CC5B68D9Q34556945-BC6FDD66-D670-48DD-A14D-A5E13C874FDDQ34988061-90296730-A541-4248-8C4B-54AC234D57EDQ34993414-E00B989E-E621-49F4-9648-93FC88D7BE64Q35026669-515FA5DE-390E-46B4-BBF6-4F03D02DBAB5Q35029095-41B45A89-760A-402A-B86B-A18ED55F6DAEQ35053524-6B0DDA3A-DC20-459E-8042-C605D09CAF26Q35606745-9031E2E0-0241-4FCE-832C-C143DBF72134Q35778791-F6522A41-EDEB-4594-BC10-B2460E042E24Q35841709-652032D5-019D-4B62-82E4-B5BABA3C35CFQ35861900-24AEB0B9-9FCB-416C-995F-8C934ADF12A7Q36139139-B0D2FC3C-3B34-4CC8-997F-DCB52043F13FQ36484091-89050538-79C1-45BE-88D4-E70102896952Q36605276-8E8A7492-497B-4341-BAC9-996B8EAFE65DQ36784958-AD1964CD-C031-4748-9DF5-18D63AA41FC5Q36939128-2F3BA7BE-771B-47AC-8734-7CFC80FA40B4Q37238777-6901F132-7659-4D01-8CA5-D4933B9232AFQ37312788-A0FA10A1-EC67-4C0C-BF84-657BF3230C53Q37335585-12EF4000-C60C-4C4B-A4C4-E595FE065E98Q37336528-2F1FBFE7-2260-40B5-B600-1D07007678D5Q37605697-3DE5F317-EE95-4B78-BC9D-317702C35D14Q37688750-E581958D-61D1-4A7A-B2CD-C18F57E3D6F1Q38064469-6DA9860C-7CC3-4B4A-981E-DC6B840937B6Q40480799-A92656D4-5C40-4641-A94D-9B987B50576FQ45397428-31D2834C-BBC7-41E3-BAF5-52E912BC1AF6Q48447189-BC32211D-6362-4A3A-8401-C2732D37A8A4Q48647459-64D4DD96-4B5F-4C5B-A9C8-1D95E645018FQ51210357-DA798FEF-AEDA-45E7-8B6A-80104E2C849CQ51988885-48AE8462-C6C9-455C-9BCE-6973B13648B1Q57273364-FC48518C-489E-4DDB-A748-6D67DF178134
P2860
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
@en
type
label
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
@en
altLabel
The Neuropathological Diagnosis of Alzheimer’s Disease: Clinical-Pathological Studies
@en
prefLabel
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
@en
P1476
The neuropathological diagnosis of Alzheimer's disease: clinical-pathological studies.
@en
P2093
P304
P356
10.1016/S0197-4580(97)00066-3
P433
P577
1997-07-01T00:00:00Z